Analystreport

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $18.00

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com